Haleon commits Rs 2,000 cr to first India plant in Pithampur, easing contract-manufacturing dependence
The Sensodyne-Crocin-Eno owner picks Madhya Pradesh for its maiden South Asia factory, a 2-3 year build backing India as its fastest-growing market. Local capacity should tighten supply for a 70% oral care share leader and underpin distribution muscle behind Centrum and Otrivin.
What happened
Haleon will invest Rs 2,000 crore to build its first India and South Asia manufacturing plant in Pithampur, Madhya Pradesh, reducing reliance on contract
Key facts
- Rs 2,000 crore
- £175 million
- 35%
- 70% oral care share
- £1.8 billion oral care market
Why this matters
Greenfield commitment in Madhya Pradesh reshapes the South Asia consumer health map, raising the bar for rivals and potentially shrinking the pool of available contract manufacturers for smaller OTC challengers.